在新生儿查期间检测到的SMN1基因的罕见变异
Maria Akhkiamova1, Aleksander Polyakov1, Andrey Marakhonov1
1Research Centre for Medical Genetics, Moskvorechie Str., 1, 115522 Moscow, Russia.
Genes
|July 27, 2024
概括
针对5q脊柱肌肉缩 (5q SMA) 的新生儿查发现了五名患有罕见SMN1基因变异的婴儿. 进一步的分析将这些变异分类为可能是良性的或具有不确定的意义的变异,在随访期间没有观察到SMA症状.
科学领域:
- 遗传学和基因组学 在
- 新生儿查 新生儿查
- 分子诊断学 分子诊断学
背景情况:
- 扩大新生儿查计划旨在早期检测遗传疾病.
- 脊柱肌缩 (SMA) 是一种严重的神经肌肉疾病.
- 精确的SMA检测依赖于SMN1基因的精确遗传分析.
研究的目的:
- 评估新生儿5q SMA查结果中的差异.
- 在查过程中发现的特定SMN1基因变异的特征.
- 通过全面分析来评估已识别的变异的临床意义.
主要方法:
- 对1,227,130个新生儿样本进行5q SMA的分析.
- 使用定量MLPA作为对不一致查结果的参考方法.
- 进行分离分析,种群携带研究和RNA分析以鉴定变体特征.
主要成果:
- 五名新生儿的查显示出由于内基 (c.835-18C>T) 或误解 (c.842G>C p.(Arg281Thr)) SMN1变异的查差异.
- 这种c.835-18C>T变种被归类为可能是良性的.
- c.842G>C p.(Arg281Thr) 变异被归类为具有不确定的临床意义的变异;在任何试验者中都没有观察到SMA症状.
结论:
- 罕见的SMN1变异可能会导致5q SMA新生儿查的差异.
- 综合性遗传和功能分析对于变异解释至关重要.
- 目前的发现表明,这些特定变异不会导致新生儿临床SMA.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
07:02Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
13.4K
相关概念视频
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Nonsense-mediated mRNA Decay
10.6K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.6K
RNA Splicing
56.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.2K
Single Nucleotide Polymorphisms-SNPs
14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K
